Cargando…
ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma
Every year, ovarian cancer kills approximately 14,000 women in the United States and more than 140,000 women worldwide. Most of these deaths are caused by tumors of the serous histological type, which is rarely diagnosed before it has disseminated. By deep paired-end sequencing of mRNA from serous o...
Autores principales: | Salzman, Julia, Marinelli, Robert J., Wang, Peter L., Green, Ann E., Nielsen, Julie S., Nelson, Brad H., Drescher, Charles W., Brown, Patrick O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176749/ https://www.ncbi.nlm.nih.gov/pubmed/21949640 http://dx.doi.org/10.1371/journal.pbio.1001156 |
Ejemplares similares
-
Low Frequency of ESRRA–C11orf20 Fusion Gene in Ovarian Carcinomas
por: Micci, Francesca, et al.
Publicado: (2014) -
Comprehensive Analysis of ESRRA in Endometrial Cancer
por: Wang, Shufang, et al.
Publicado: (2021) -
Declined expressions of vast mitochondria-related genes represented by CYCS and transcription factor ESRRA in skeletal muscle aging
por: Kan, Jingbao, et al.
Publicado: (2021) -
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
por: Sato, Sho, et al.
Publicado: (2023) -
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
por: Smebye, Marianne Lislerud, et al.
Publicado: (2017)